Dr. William Jeffery Edenfield Jr., MD

Dr. Edenfield practices at Prisma Health Greenville Memorial Hospital in Greenville, South Carolina, part of Prisma Health.

Dr. Edenfield's NPI, 1851396295, was assigned on June 14, 2005. Dr. Edenfield graduated from University of Miami, Lm Miller School of Medicine in 1992. Dr. Edenfield holds South Carolina license 23721.

Dr. Edenfield's primary practice is Prisma Health Greenville Memorial Hospital, at 701 Grove Road, Greenville, SC 29605 in Greenville County. The practice phone is (864) 455-7000.

Dr. Edenfield's primary practice is Prisma Health Greenville Memorial Hospital in Greenville, South Carolina, part of Prisma Health. Dr. Edenfield is also affiliated with Bon Secours St. Francis Downtown. The medical group on file is Prisma Health Medical Group. Dmand AI also links Dr. Edenfield to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Edenfield practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Edenfield's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Edenfield is licensed in South Carolina.

CMS data shows 1,169 Medicare services from Dr. Edenfield across 4 procedure codes in 2024, for 305 Medicare patients. Medicare paid $45,630 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 305 Medicare patients who saw Dr. Edenfield in 2024. The largest group is 65 to 74, with 143 patients. 75% of them have high cholesterol, and 74% have cancer. 4% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Edenfield's median patient age at 67, with 78% women.

In 2024, Dr. Edenfield wrote 886 Medicare Part D claims for 186 patients. 87% of them were for generic drugs. CMS names the drug for 611 of them, across 18 drugs with 11 or more claims each, at $642,424 in total drug cost. In 2023, CMS named 725 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Edenfield for performance year 2024, reported as part of a group. Dr. Edenfield accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Edenfield to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Melanoma and Nevi and Melanomas. Bristol-Myers Squibb sponsors the most, 3. Open Payments lists research payments to Dr. Edenfield that name 3 trials.

CMS Open Payments shows 153 general payments to Dr. Edenfield from 37 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 59% of the total. Pfizer Inc. paid the most, $8,142. It also lists 7 research payments totaling $72,032 from 2016 to 2019, naming 3 clinical trials.

Dr. Edenfield graduated from University of Miami, Lm Miller School of Medicine in 1992.